AnaptysBio Inc. (ANAB)
14.65
-2.17 (-12.90%)
At close: Mar 03, 2025, 3:59 PM
14.75
0.68%
After-hours: Mar 03, 2025, 04:19 PM EST
AnaptysBio Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -145.23M | -163.62M | -128.72M | -57.8M | -19.93M | -97.34M | -61.66M | -30.07M | -4.26M | -5.41M | 3.53M | -5.54M |
| Depreciation & Amortization | 2.4M | 2.38M | 2.33M | 2.09M | 559K | 514K | 315K | 183K | 233K | 274K | 308K | 580K |
| Stock-Based Compensation | 34.05M | 33.2M | 27.36M | 15.35M | 11.5M | 12.41M | 9.96M | 4.38M | 1.16M | 604K | 160K | 151K |
| Other Working Capital | n/a | -11.26M | -2.32M | -1.87M | 2.11M | 2.35M | -3.62M | 238.61M | -2.94M | -9.05M | 10.73M | -1.39M |
| Other Non-Cash Items | -26.55M | 7.56M | 18.6M | 1.45M | 487K | 676K | 646K | 619K | 105K | 110K | 1.27M | 886K |
| Deferred Income Tax | n/a | n/a | n/a | 478K | n/a | -2.63M | -1.23M | 1.38M | 757K | 1.28M | 62K | -621K |
| Change in Working Capital | n/a | -324K | 6.84M | -7.49M | -6.77M | 16.85M | 3.46M | 4.08M | -7.03M | -6.53M | 9.27M | -1.25M |
| Operating Cash Flow | -135.34M | -120.8M | -73.59M | -45.92M | -14.16M | -69.52M | -48.51M | -19.44M | -9.03M | -9.67M | 14.6M | -5.8M |
| Capital Expenditures | -358K | -807K | -358K | -1.37M | -569K | -805K | -1.06M | -290K | -50K | -238K | -145K | -37K |
| Acquisitions | n/a | n/a | 394.49M | 15K | 194.93M | 251.81M | 347.54M | 290.9M | n/a | n/a | n/a | n/a |
| Purchase of Investments | -380.38M | -303.92M | -802.5M | -118.66M | -194.93M | -251.81M | -347.54M | -290.9M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 476.13M | 449.48M | 408.02M | 158.85M | 289.97M | 384.05M | 206.15M | 48.14M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | -394.49M | 40.2M | -194.93M | -251.81M | -347.54M | -290.9M | n/a | n/a | 5K | n/a |
| Investing Cash Flow | 95.4M | 144.75M | -394.85M | 38.84M | 94.47M | 131.43M | -142.45M | -243.06M | -50K | -238K | -140K | -37K |
| Debt Repayment | n/a | -11.73M | n/a | n/a | -1.38M | -7.5M | -6.88M | n/a | 10M | n/a | 5M | 1.96M |
| Common Stock Repurchased | -456K | -50M | n/a | n/a | n/a | n/a | n/a | n/a | -1K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 127.05M | -43K | 32.19M | 249.75M | n/a | n/a | 2.76M | -84K | -1.37M | 39.24M | -85K | n/a |
| Financial Cash Flow | 127.05M | -59.3M | 44.02M | 252.3M | -879K | -4.49M | 223.36M | 292.45M | 8.63M | 39.4M | 4.92M | 1.96M |
| Net Cash Flow | 87.11M | -35.34M | -424.42M | 245.21M | 79.44M | 57.42M | 32.41M | 29.96M | -452K | 29.5M | 19.38M | -3.87M |
| Free Cash Flow | -135.69M | -121.61M | -73.95M | -47.29M | -14.73M | -70.32M | -49.57M | -19.73M | -9.08M | -9.91M | 14.46M | -5.83M |